ProductTopical treatment designed to improve minoxidil efficacy.
StudiesClinically shown to increase the enzymes needed for minoxidil to work, sulfotransferase enzymes, by up to 7x over a two-week period.
Sales Channels
Licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, with their commercial launch planned for 2023.
Licensed to India-based Cosmofix Technovation Pvt Ltd and Sanpellegrino Cosmetics with product launch planning underway.
Next StepsAdditional licensing opportunities are being pursued abroad.
For up-to-date company news delivered straight to your inbox or phone, sign up for Investor Alerts today.
To receive alerts via text message, send JUPW to +1 (844) 819-8138